baber/WOPTO huggingface dataset:
Patent NZ-336290-A (NZ)
Title: Method for coating cheese with a hydrophobic layer and a hydrophilic layer and resulting coated cheese
Inventor: GOLDSCHMIDT BENOIT
IPC: A23C19/16
Filed: 1997-12-10
Abstract: A method for coating cheese with an edible coating is provided.  The method involves applying successively at least one layer of an edible hydrophobic composition, and at least one layer of an edible hydrophilic composition, directly onto the cheese.  An emulsifying agent is present in the hydrophobic layer adjacent to a hydrophilic layer, the hydrophilic layer adjacent to a hydrophobic layer or to the interface between a hydrophobic layer and a hydrophilic layer.
Patent NZ-502631-A (NZ)
Title: Oral use calcium containing solid composition for use in reducing tooth erosion
Inventor: PARKER DAVID MYATT
IPC: A23L1/304
Filed: 1998-08-11
Abstract: A solid or semi-solid composition, for oral use, for reducing tooth erosion that contains a calcium compound and an acidulant.  The calcium is present in the range of 0.3 to 0.65 mol per mol of acid and the proportion of the calcium and acidulant in the composition is selected so that the effective pH is from 3.5 to 4.5.
Patent NZ-502819-A (NZ)
Title: Inhibiting stenosis and/or restenosis using for platelets and a human constant region
Inventor: COLLER BARRY S
IPC: A61K38/00
Filed: 1994-11-07
Abstract: Platelet-specific, chimeric immunoglobulin and immunoglobulin fragments are described. The chimeric molecules are made up of a nonhuman antigen binding region and a human constant region. Preferred immunoglobulins are specific for glycoprotein IIb/IIIa receptor in its complexed form; they block ligand binding to the receptor and prevent platelet aggregation. The immunoglobulins can be used to reduce or prevent occlusion, reocclusion (e.g, abrupt closure), stenosis and/or restenosis. In addition, the immunoglobulins are useful in anti-thrombotic therapy when administered alone or in conjunction with thrombolytic agents, as well as in thrombus imaging.
Patent NZ-503319-A (NZ)
Title: Streptococcus lactic acid bacteria strains whose total protein profile resembles that of CNCM I-1920
Inventor: GAIER WALTER
IPC: A61P3/02
Filed: 1998-10-09
Abstract: A lactic acid bacteria strain, where the 16S ribosomal RNA is characteristic of the genus Streptococcus; and whose total protein profile, obtained after culture of the bacterium in MRS media for 24h at 28°C, extraction of the total protein, and migration of the protein on SDS-PAGE gel electrophoresis, exhibits a degree of Pearson correlation of at least 78 with respect to the profile obtained under identical conditions with the strain of lactic acid bacterium CNCM I-1926.
Patent NZ-504194-A (NZ)
Title: Physiologically acceptable aqueous solutions and methods for their use
Inventor: SEGALL PAUL E
IPC: A61K31/715
Filed: 1997-10-31
Abstract: An physiologically acceptable aqueous solution comprising: (1) electrolytes, (2) a dynamic buffering system, (3) at least one oncotic agent weight fraction of an initial oncotic agent source, wherein the weight fraction ranges from about 50 000 to 1 000 000 daltons. Wherein the solution comprises at least two of magnesium, a sugar in an amount of not more than about 50 mM and a medium or high molecular weight oncotic agent, and does not include a biological buffer. The described aqueous solution can be introduced into the circulatory system of a host as a plasma substitute solution.
Patent NZ-504504-A (NZ)
Title: Vaccine compositions comprising chitosan for mucosal administration for enhancing IgA mucosal and IgG systemic immune responses
Inventor: MAKIN JILL CATHERINE
IPC: A61K39/145
Filed: 1998-11-27
Abstract: A vaccine composition adapted for mucosal, particularly intra nasal, administration is described.  The composition comprises one or more influenza vaccine antigens and an effective adjuvant amount of an acid addition salt of a chitosan wherein the chitosan is a deacetylated chitin which is at least 80 % deacetylated and has an apparent viscosity of less than 10mPas in a 1% w/v solution at 25oC in 0.9% NaCl.
Patent NZ-507725-A (NZ)
Title: Biodegradable animal chew moulded from composition of polyesteramide and starch
Inventor: AXELROD GLEN S
IPC: A23K1/18
Filed: 2000-10-24
Abstract: A biodegradable dog chew is injection moulded from a mixture of polyesteramide and starch, the starch being in a continuous phase, and the polyesteramide being in a discrete discontinuous (granular within the chew) phase.
Patent NZ-511933-A (NZ)
Title: Multivalent T.D. polio vaccine against at least diphtheria, poliomyelitis and tetanus
Inventor: CARTIER JEAN RENE
IPC: A61P25/00
Filed: 1999-11-25
Abstract: Vaccine formulated for exclusive use as a repeat ('booster') vaccine in a population already having received a primary vaccine and/or sensitized against at least the poliovirus, Corynebacterium diphteriae and/or C. tetani, is new. Vaccine (I) formulated for exclusive use as a repeat ('booster') vaccine in a population already having received a primary vaccine and/or sensitized against at least the poliovirus, Corynebacterium diphteriae and/or C. tetani, comprises, (1) at least 1.2 mg/ml of aluminum salt; (2) antigens derived from at least the poliovirus; and (3) a quantity of diphtheria anatoxin (DA) used as an antigen of C. diphteriae comprising between 4-16 Flocculation units (Fu);
Patent NZ-515143-A (NZ)
Title: Aminoindane piperidine compounds as dermal anesthetic agents
Inventor: ABERG A K GUNNAR
IPC: A61K31/445
Filed: 2000-06-06
Abstract: Disclosed herein are aminoindane piperidine compounds, compositions containing these compounds and a method of using these compounds as local anesthetics. These compounds particularly have properties as dermal and topical anesthetics in mammals, including man,
Patent NZ-515329-A (NZ)
Title: Isolating biological modulators from biodiverse gene fragment libraries
Inventor: WATT PAUL MICHAEL
IPC: C07K7/08
Filed: 2000-05-05
Abstract: A method of identifying nucleic acid that encodes a peptide having a conformation sufficient for binding to a target protein or nucleic acid. The peptide does not bind to the protein or nucleic acid in its native environment. The method comprises: a) constructing an expression library by a disclosed process; and b) screening expression library to identify a nucleic acid fragment that encodes a peptide that binds to the target protein or nucleic acid; and c) selecting a nucleic acid fragment at (b) that encodes a peptide that does not bind to target protein or nucleic acid in its native environment.
Patent NZ-516986-A (NZ)
Title: Preparing an alpha, beta unsaturated ketones by condensing aldehydes with ketones via a multiphase reaction in a tubular reactor
Inventor: BUSCHKEN WILFRIED
IPC: C07C49/203
Filed: 2002-02-01
Abstract: A process for preparing a,b-unsaturated ketones of formula R2-CH=C(R3)-C(=O)-R1 comprises reacting an aldehyde -R2-C(=O)H with a ketone -R3-CH2-C(=O)-R1.  The catalyst is present in continuous phase and at lest only one reactant is present in dispersed phase and the loading factor of the tubular rector is not less than 0.8 wherein: R1 and R2 are independently an optionally saturated aliphatic, cycloaliphatic or cycloaliphatic-aliphatic hydrocarbon, which may contain alkyl substituents and/or endo-alkylene groups or can be an aromatic hydrocarbon; R3 is H, or an aliphatic hydrocarbon or together with R1 and the adjacent carbons form an alicyclic ring and in R1 to R3 one or more methylene groups which are not a disposed relative to the carbonyl groups may be substituted with a oxygen or sulphur atom.
Patent NZ-517345-A (NZ)
Title: Special backflow preventer
Inventor: HALL DAVID ROBERT WYNTER
IPC: F16K1/26
Filed: 2002-02-22
Abstract: The apparatus disclosed relates to a method of allowing water to only flow in one direction down a pipe, such as low-pressure drains. The apparatus can also be used to prevent flood waters flowing back up the pipe. The apparatus consists of a chamber (1) at the end of the pipe (2) with an inverted "U" shaped cross section. A waterproof sheet is attached to the pipe to act as a form of one-way valve. The sheet may be made of rubber or similar materials. The water flowing (7) down the pipe pushes the sheet up and escapes with little resistance. Water flowing in the reverse direction will cause the loose edge of the sheet to fall under gravity and prevent such backflows.
Patent NZ-518112-A (NZ)
Title: Phenyl- and pyridyl-tetrahydropyridines having TNF inhibiting activity
Inventor: BARONI MARCO
IPC: B29D35/06
Filed: 2000-10-19
Abstract: A tetrahydropyridine derivative or a salt or solvate thereof has the formula (I) wherein: X is N or CH; R1 is a hydrogen, halogen or CF3; R2 and R3 independently are hydrogen or methyl; n is 0 or 1; A is a group of formula (a) or (b); R4 is a hydrogen, halogen, alkyl, CF3, amino, monoalkylamino or dialkylamino; R5 is hydrogen, halogen, alkoxy, alkyl or CF3 and R6 is hydrogen, alkyl or alkoxy. A piperidine derivative a salt or solvate thereof has the formula (IV) or (V) wherein: R1 to R6, n, X and A are as defined above. The compounds are useful in treating immune or inflammatory disorders.
Patent NZ-519390-A (NZ)
Title: 7-Chloro-4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione useful for treating pain
Inventor: BARE THOMAS MICHAEL
IPC: C07D471/04
Filed: 2000-12-19
Abstract: 7-Chloro-4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione or a pharmaceutically acceptable salt thereof such as the choline salt  is useful for treating pain.
Patent NZ-523472-A (NZ)
Title: Method of providing a thermally-processed commodity within a plastic container
Inventor: BOYD TIMOTHY J
IPC: B65B61/00
Filed: 2001-06-29
Abstract: A method for providing a thermally processed commodity in a plastic container. The container is exposed to elevated temperatures to form an intermediate finish section. A commodity is dispensed within the plastic container. A closure engages the intermediate finish section. The finish section being within a predetermined range whereby the finish section and the closure result in retaining a hermetic seal.
Patent NZ-526178-A (NZ)
Title: Dyed nonfelting keratin fibres and preparation thereof
Inventor: JANSEN BERNHARD
IPC: D06P5/20
Filed: 2003-05-28
Abstract: A process for dyeing and anti-felt finishing of keratin fibres, in which the keratin fibres are exposed to three treatment steps, (a) plasma treatment; (b) treatment with an aqueous dispersion of a cationic polyurethane; and (c) dyeing. The steps are effected in any order. The process can utilize a wide variety of types of keratin fibres, preferably wool, but including animal hairs other than wool and also human hair.
Patent NZ-528518-A (NZ)
Title: A process for the preparation of a high protein hydrolysate
Inventor: CHERUPPANPULLIL RADHA
IPC: A23L1/305
Filed: 2001-03-30
Abstract: A process for the preparation of a high protein hydrolysate, said process comprising: (a) selecting two or more protein material in the form of defatted oilseed flours; (b) mixing the defatted oilseed flours; (c) dispersing the mixed flour obtained from step (b) in aqueous medium at a controlled temperature and alkaline pH for 1-2 hours to form a slurry; (d) raising the temperature of the slurry up to 40-50°C; (e) hydrolyzing the slurry obtained in step (d) using fungal enzyme at controlled temperature for 2-3 hours; (f) raising the temperature of the slurry from step (e) up to 50-60°C; (g) hydrolyzing the slurry of step (f) with plant enzyme at a temperature of 50-60°C for 1-2 hours; (h) deactivating the residual enzyme by keeping the slurry on a waterbath for 10-15 minutes at 90-100°C; (i) recovering a low molecular weight protein hydrolysate from the protein fraction of the hydrolysis step (h) by centrifugation; and hydrolysate.
Patent NZ-529898-A (NZ)
Title: A method of paying parking fees for a parked vehicle using a mobile device such as a cellular phone
Inventor: ALLEN KIM SHAWN
IPC: H04Q7/22
Filed: 2003-12-01
Abstract: A distributed paring system comprises: a local proximity reader to read user identification information from a windscreen mounted Radio Frequency Identification (RFID) card, and a mobile commerce platform for payment of parking fees using a mobile transmitter device with the mobile commerce platform including a server to receive the user identification information, the parking location information for identifying the location of a parked vehicle and payment related information for payment of the parking fee. The server receives the transmitted information, associates the parking location information and the payment related information with the user identification information, records the associated transmitted information and charges the parking fee to the account of the user.
Patent NZ-537904-A (NZ)
Title: Neisserial vaccine compositions comprising a combination of antigens
Inventor: BERTHET FRANCOIS-XAVIER JACQUE
IPC: A61K39/00
Filed: 2003-07-31
Abstract: Disclosed is an immunogenic composition comprising either or both of LPS immunotype L2 and LPS immunotype L3 and one or more different antigens selected from at least one of the following categories: a) at least one Neisserial adhesin; b) at least one Neisserial autotransporter; c) at least one Neisserial Fe acquisition protein; or d) at least one Neisserial membrane associated protein; and wherein the antigens, where present in an outer membrane vesicle, have been upregulated in the outer membrane vesicle.
Patent NZ-540464-A (NZ)
Title: Slide out for a motor home, with telescoping support members having snug fit with each other
Inventor: MACLEAN COLIN
IPC: B60P3/34
Filed: 2005-06-01
Abstract: A vehicle is disclosed having a slide out includes a vehicle body having a wall including two side wall sections and defining a vehicle interior. At least one slide out body member extends across an opening in a side wall section of the vehicle body that is capable of movement between a laterally expanded position during recreational use of the vehicle and a retracted position during use of the vehicle for travel on the roads. The slide out body member has a primary wall portion for covering at least a portion of the side wall section of the vehicle body and the body member also including end walls and a bottom and roof extending transverse to the primary wall portion in a direction into the vehicle body so that the space defined by the slide out member opens into and forms part of the vehicle interior. A support supports the body member on the body of the vehicle in a way that permits sliding of the slide out relative to the body of the vehicle between the expanded and retracted positions. A drive moves the body member between said expanded and retracted positions on said support.
Patent NZ-542837-A (NZ)
Title: Flute holder
Inventor: ERNST RICHARD J
Filed: 2005-10-06
Abstract: Flute holders for holding fasteners and being insertable into a fastener driving tool are disclosed. The holders include a bracket-engaging portion (12), a tool-engaging sleeve (14)connected to the bracket-engaging portion, fins that extend radially outward from the sleeve to engage the tool, and a holding passage (16) that is at least partially within the sleeve. In one embodiment the sleeve has a cylindrical washer region (36) adjacent the bracket-engaging portion, where the washer region has an increased wall thickness relative to a portion of the upper end of the sleeve.
Patent NZ-544204-A (NZ)
Title: Waste treatment system
Inventor: MORLEY SHERIDAN
Filed: 2005-12-15
Abstract: A waste treatment system having a primary tank (12) which communicates with an aeration tank (32) which in turn communicates with a humus tank (34). The aeration tank and humus tank are separated by a baffle wall (36) and a filter unit sits on the baffle wall. The filter unit has a first chamber (121) which supports a first container (125) and a second chamber (122) which supports a second container (125). The containers are in the form of buckets having holes in their bottom surface (126) and which contain filter medium. Water flow from the aeration tank is up through the bucket and first chamber and then into the humus tank. The water can then flow from the humus tank through the second bucket and second chamber to an outlet conduit (80).
Patent NZ-547245-A (NZ)
Title: Conductive, EMI shielding and static dispersing laminates and method of making same
Inventor: KAZAKEVICS ARNIS
Filed: 2006-05-16
Abstract: A method of manufacturing a laminate including the steps of: (i) dispersing an amount of carbon nanotubes in a curable resin; (ii) coating a semi-permeable substrate with the carbon nanotube containing resin; (iii) pressing said coated semi substrate; and (iv) at least partially curing said resin such that said carbon nanotubes are bound to said substrate and are present in an amount between 0.1 wt% and 99 wt% in said at least partially cured resin. These laminates have anti-static, electrostatic dissipative, electromagnetic interference (EMI) shielding and conductive properties, and they are suitable for applying to surfaces of articles or buildings.
Patent NZ-549355-A (NZ)
Title: Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
Inventor: BALTHASAR SABINE
IPC: A61K39/395
Filed: 2005-03-02
Abstract: Provided is a carrier system for the cell-specific, intracellular enrichment of at least one pharmacologically active substance, wherein said carrier system is present in the form of nanoparticles based on gelatin and/or serum albumin and wherein said carrier system has structures that are coupled by means of reactive groups, wherein said structures are biotinylated, cell-specific antibodies which enable a cell-specific attachment and cellular absorption of the nanoparticles, said antibodies being bound to said reactive groups by avidin-biotin complex formation. Also provided are methods of producing such carrier systems.
Patent NZ-562362-A (NZ)
Title: Injection device (adaptable device)
Inventor: BARROW-WILLIAMS TIMOTHY DONALD
IPC: A61M5/32
Filed: 2006-03-21
Abstract: An injection device 110 comprises a housing 112 adapted to receive a syringe 114 with a discharge piston and a needle 118, a syringe drive 130 and a drive coupling that extends from the syringe drive 130 to the syringe piston. The syringe drive 130 acts on the syringe 114 to move it from a position where the syringe needle 118 is inside the housing 112 to a position where the syringe needle 118 extends from the housing 112. A drive coupling extends from the syringe drive 130 to the syringe piston and transfers the movement of the drive 130 to the piston. The drive coupling comprises a fixed length drive coupling 134, an interchangeable drive coupling and an interchangeable release element that actuates a delay mechanism in the action of the syringe drive on the fixed length coupling after the piston has moved a predetermined distance.
Patent NZ-565904-A (NZ)
Title: Chimeric antibodies with New World primate CDR regions
Inventor: JENNINGS PHILIP ANTHONY
IPC: C12P21/08
Filed: 2006-08-15
Abstract: A chimeric antibody that comprises at least two complementarity determining regions (CDR) and at least three framework regions, wherein at least one CDR is a New World primate CDR2 that has a sequence selected from KVSNRAS, RVSNRAS, KVSTRGP, AASNRAS, TSSNLQA and YASFLQG.
Patent NZ-567133-A (NZ)
Title: Deazapurines useful as inhibitors of janus kinases
Inventor: SALITURO FRANSCESCO
IPC: A61K31/495
Filed: 2006-09-28
Abstract: Disclosed is a pyrimidine having the formula (I) or a pharmaceutically acceptable salt thereof, wherein each of Z1, Z2, and Z4 is, independently, CH or N, wherein at least one of Z1 or Z2 is N, R1, R2, JQ, JQ1 and JQ2 is defined in the specification. Also disclosed is the use of said compound for the treatment of allergic or type I hypersensitivity reactions, asthma, diabetes, Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS-associated dementia, amyotrophic lateralsclerosis, multiple sclerosis, schizophrenia, cardiomyocyte hypertrophy, reperfusion/ischemia, stroke, baldness, transplant rejection, graft versus host disease, rheumatoid arthritis, a solid malignancy, a hematologic malignancy, a leukemia, a lymphoma and a myeloproliferative disorder.
Patent NZ-572584-A (NZ)
Title: Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
Inventor: SHERRIS DAVID I
IPC: A61K8/36
Filed: 2006-10-12
Abstract: Disclosed is a composition comprising a benzo(c)chromen-6-one compound as depicted in the drawing as SG00529 or SG00574. 3-(4-methoxy-Benzyloxy)-8-(1-hydroxyethyl)-2-methoxy-6H-benzo[c]chromen-6-one is possibly the name of SG00529 Also disclosed is the use of the compounds for the manufacture of a medicament for preventing and/or treating a skin disease.
Patent NZ-584997-A (NZ)
Title: Anti-hepcidin antibodies and uses thereof
Inventor: CAI YUPING ANTHONY
IPC: C07K16/18
Filed: 2008-10-29
Abstract: Provided is an isolated antibody that binds human hepcidin-25 with a KID of about 800 pM or less as determined by surface plasmon resonance (SPR) at 25 °C and comprises six CDRs consisting of LCDR1, LCDR2, LCDR3, HCDR1, HCDR2, and HCDR3 having specified amino acid sequences. The antibody can be used for increasing serum iron levels, reticulocyte count, red blood cell count, haemoglobin, or haematocrit in a subject.
Patent NZ-587198-A (NZ)
Title: Monoclonal antibodies against the rgm a protein and uses thereof
Inventor: MULLER BERNHARD K
IPC: A61K39/395
Filed: 2009-02-27
Abstract: Disclosed is an isolated antibody comprising an antigen binding domain, said antibody capable of binding an epitope of a RGM molecule, said antigen binding domain comprising a heavy chain variable domain having at least three complementary determining regions and a light chain variable domain having at least three complementary determining regions, wherein the at least three complementary determining regions of the heavy chain variable domain have the amino acid sequence of SEQ ID NO:57, SEQ ID NO:58 and SEQ ID NO:59 and the at least three complementary determining regions of the light chain variable domain have the amino acid sequence of SEQ ID NO: 60, SEQ ID NO:61 and SEQ ID NO:62. Further disclosed is an isolated antibody comprising an antigen binding domain, said antibody capable of binding an epitope of a RGM molecule, said antigen binding domain comprising a heavy chain variable domain and a light chain variable wherein the heavy chain variable domain has the amino acid sequence selected from the group consisting of: SEQ ID NOS: 35, 36, 37, 38, 39, 40, 41, 42, 43, 47, 48, 49 and 50 and wherein the light chain variable domain has the amino acid sequence selected from the group consisting of SEQ ID NO:44, 45, 46, 51, 52, 53 and 54.
Patent NZ-587622-A (NZ)
Title: Noribogaine compositions
Inventor: MORIARTY ROBERT M
IPC: C07D209/56
Filed: 2010-08-27
Abstract: Disclosed is a composition comprising noribogaine (as depicted) wherein at least 95 percent of the noribogaine is present as the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and further wherein said composition comprises less than 100 ppm ibogaine contamination relative to the total amount of noribogaine.